Success Story: From RFE to Approval: NIW Win for A Chinese Manager of Biostatistics Thanks to Our Expert Team
Client’s Testimonial:
“Thank you very much for preparing the NIW case for me with patience and professionalism. I really appreciate it. Will recommend to my friends if they need similar services.”
On April 22nd, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Manager of Biostatistics in the Field of Biostatistics (Approval Notice).
General Field: Biostatistics
Position at the Time of Case Filing: Manager of Biostatistics
Country of Origin: China
State of Residence at the Time of Filing: New Jersey
Approval Notice Date: April 22nd, 2025
Processing Time: 21 months, 25 days
Case Summary:
We are pleased to share the approval of a National Interest Waiver (NIW) petition filed for a PhD holder whose work lies at the intersection of biomedical data analysis, clinical trials, and public health. The petition was approved in April 2025, following a successful response to a Request for Evidence (RFE).
The client’s proposed endeavor focuses on analyzing biomedical and clinical data to advance drug development and data-driven medical decisions. Their work supports the design of clinical trials and statistical frameworks that inform therapeutic strategies for serious health challenges such as cancer and oral disease. The broader goal of this research is to optimize treatment outcomes, enhance public health interventions, and reduce disease burden through innovative biostatistical methods.
At the time of filing, the client was employed in the pharmaceutical sector as a biostatistics manager, contributing to projects that improve clinical trial efficacy and help shape drug development strategies. Their research efforts include statistical model development, outcome analysis, and experimental design, with a focus on real-world applications.
To date, the client has authored 15 peer-reviewed journal articles, including 2 first-authored papers. Their work has been cited 82 times, and they have served as a reviewer for esteemed journals in the field, completing at least 2 peer reviews. Several of their publications are among the most highly cited in Clinical Medicine for their publication years, highlighting the impact and influence of their work within the scientific community.
The NIW petition emphasized the national relevance of the client’s contributions, citing research that has advanced understanding in areas such as oral microbiota development, osteoporosis-related jaw bone changes, and treatment optimization frameworks in clinical medicine. Their findings have been incorporated into studies around the world and funded by major U.S. public health institutions, underscoring their practical utility and alignment with national healthcare goals.
The petition included 4 letters of recommendation from field experts, including several independent references.
“His unique perspective, phenomenal credentials, and innovative research have enabled him to drive biostatistics forward to the benefit of not just his fellow researchers, but the healthcare system at large.”
This approval reflects the importance of biostatistical innovation in shaping the future of evidence-based healthcare. We are proud to have helped secure a successful outcome for this researcher and look forward to their continued contributions to medical data science and public health advancement.